این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Journal of Research in Medical Sciences، جلد ۱۷، شماره ۶، صفحات ۰-۰
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Response rates to HB vaccine in CKD 3-4 and hemodialysis patients
چکیده انگلیسی مقاله Normal 0 false false false EN-US X-NONE AR-SA MicrosoftInternetExplorer4 Background: Hepatitis-B virus (HBV) infection is a big problem in chronic kidney disease (CKD) population. We attempted to compare the response rate to HB vaccine in CKD stages3-4 patients with that in hemodialysis (CKD stage-5; HD patients) and medical staff. Materials and Methods: Three hundred and three participants were enrolled into the study to test the seroconversion rate after vaccination. Participants formed three groups: GroupA:HD patients, GroupB: diagnosed with CKD stages34, and GroupC: healthy medical staff. CKD stages34 participants were vaccinated from February to November 2010. HD patients were vaccinated at the time of initial HD and medical staff at the time of being hired. GroupA, GroupB and GroupC received four 40μg(in 0,1,2 and 6 months), three 40μg(0, 1 and 6 months) and three 20μg(0, 1and 6 months) doses of HB vaccine, respectively. Three months after completion of the vaccination schedule, seroconversion and seroprotection rates in each group were investigated. Results: Seroconversion rates were 44.3%, 89.7%, and 96.2% for groups A, B and C, respectively. CKD stages 34 patients showed higher response rate than dialysis patients [ χ 2(1):30.6, P < 0.001]. But a significant difference in the seroconversion rate between CKD stages34 patients and medical staffs was not observed [ χ 2(1):3.4, P = 0.064]. Multivariate analyses showed patients with more advanced CKD and who were older had less seroconversion rates [odds ratio: 0.09(95%CI: 0.040.25) and [odds ratio: 0.39(95% CI: 0.180.85)], respectively. But sex was not associated with seroconversion ( P >0.05). Conclusion: Stages34 patients with higher dosages of routine HB vaccine had higher seroconversion rate than HD patients. Future studies should evaluate the recommended dosage of HB vaccine among these patients.
کلیدواژه‌های انگلیسی مقاله
نویسندگان مقاله محمد h قدیانی | mohammad h ghadiani
department of nephrology, taleghani hospital, shahid beheshti university of medical sciences, tehran, iran

سازمان اصلی تایید شده: دانشگاه علوم پزشکی شهید بهشتی (Shahid beheshti university of medical sciences)

شاهین بشارتی | shahin besharati
department of internal medicine,vali-e-asr hospital, zanja n university of medical sciences, zanjan, iran


نورالدین موسوی نسب | nouraddin mousavinasab
department of social medicine, school medicine, zanjan university of medical sciences, zanjan, iran

سازمان اصلی تایید شده: دانشگاه علوم پزشکی زنجان (Zanjan university of medical sciences)

مژگان جلال زاده | mojgan jalalzadeh
departments of nephrology, imam hossein hospital, shahid beheshti university of medical sciences, tehran, iran

سازمان اصلی تایید شده: دانشگاه علوم پزشکی شهید بهشتی (Shahid beheshti university of medical sciences)

نشانی اینترنتی http://jrms.mui.ac.ir/index.php/jrms/article/view/8486
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده Original Articles
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات